Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization

L. C. Shaw, H. Pan, A. Afzal, S. L. Calzi, P. E. Spoerri, S. M. Sullivan, M. B. Grant

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Insulin-like growth factor-I (IGF-I) and its receptor (IGF-IR) are essential for normal ocular development and are expressed in numerous ocular cell types including lens epithelial cells, retinal pigment epithelial cells, Müller cells and endothelial cells. Endothelial cell proliferation is a common feature of proliferative retinopathies and involves abnormal growth of blood vessels within and on the surface of the retina. In an effort to inhibit the formation of these aberrant blood vessels, we cloned an IGF-IR ribozyme into an expression vector that limits expression of the ribozyme to proliferating endothelial cells. An endothelin enhancer and Cdc6 promoter chimera drives expression of the IGF-IR ribozyme. This promoter limited retinal expression of the reporter gene to proliferating endothelial cells in two mouse models of proliferative retinopathy. In addition, expression of the IGF-IR ribozyme by this promoter inhibited aberrant retinal angiogenesis in both models while preserving normal vessels. These results demonstrate the feasibility of IGF-IR ribozyme expression in a selective manner for safer treatment of abnormal angiogenesis associated with retinopathy.

Original languageEnglish (US)
Pages (from-to)752-760
Number of pages9
JournalGene Therapy
Volume13
Issue number9
DOIs
StatePublished - May 2006
Externally publishedYes

Fingerprint

Retinal Neovascularization
Catalytic RNA
IGF Type 1 Receptor
Endothelial Cells
Blood Vessels
Epithelial Cells
Retinal Pigments
Endothelins
Reporter Genes
Lenses
Retina
Cell Proliferation
Growth

Keywords

  • Endothelial
  • IGF-I
  • Proliferating
  • Promoter
  • Retinopathy
  • Ribozyme

ASJC Scopus subject areas

  • Genetics

Cite this

Shaw, L. C., Pan, H., Afzal, A., Calzi, S. L., Spoerri, P. E., Sullivan, S. M., & Grant, M. B. (2006). Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization. Gene Therapy, 13(9), 752-760. https://doi.org/10.1038/sj.gt.3302718

Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization. / Shaw, L. C.; Pan, H.; Afzal, A.; Calzi, S. L.; Spoerri, P. E.; Sullivan, S. M.; Grant, M. B.

In: Gene Therapy, Vol. 13, No. 9, 05.2006, p. 752-760.

Research output: Contribution to journalArticle

Shaw, LC, Pan, H, Afzal, A, Calzi, SL, Spoerri, PE, Sullivan, SM & Grant, MB 2006, 'Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization', Gene Therapy, vol. 13, no. 9, pp. 752-760. https://doi.org/10.1038/sj.gt.3302718
Shaw, L. C. ; Pan, H. ; Afzal, A. ; Calzi, S. L. ; Spoerri, P. E. ; Sullivan, S. M. ; Grant, M. B. / Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization. In: Gene Therapy. 2006 ; Vol. 13, No. 9. pp. 752-760.
@article{0ed68c90fd4245c7b0118fcb07d788e8,
title = "Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization",
abstract = "Insulin-like growth factor-I (IGF-I) and its receptor (IGF-IR) are essential for normal ocular development and are expressed in numerous ocular cell types including lens epithelial cells, retinal pigment epithelial cells, M{\"u}ller cells and endothelial cells. Endothelial cell proliferation is a common feature of proliferative retinopathies and involves abnormal growth of blood vessels within and on the surface of the retina. In an effort to inhibit the formation of these aberrant blood vessels, we cloned an IGF-IR ribozyme into an expression vector that limits expression of the ribozyme to proliferating endothelial cells. An endothelin enhancer and Cdc6 promoter chimera drives expression of the IGF-IR ribozyme. This promoter limited retinal expression of the reporter gene to proliferating endothelial cells in two mouse models of proliferative retinopathy. In addition, expression of the IGF-IR ribozyme by this promoter inhibited aberrant retinal angiogenesis in both models while preserving normal vessels. These results demonstrate the feasibility of IGF-IR ribozyme expression in a selective manner for safer treatment of abnormal angiogenesis associated with retinopathy.",
keywords = "Endothelial, IGF-I, Proliferating, Promoter, Retinopathy, Ribozyme",
author = "Shaw, {L. C.} and H. Pan and A. Afzal and Calzi, {S. L.} and Spoerri, {P. E.} and Sullivan, {S. M.} and Grant, {M. B.}",
year = "2006",
month = "5",
doi = "10.1038/sj.gt.3302718",
language = "English (US)",
volume = "13",
pages = "752--760",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization

AU - Shaw, L. C.

AU - Pan, H.

AU - Afzal, A.

AU - Calzi, S. L.

AU - Spoerri, P. E.

AU - Sullivan, S. M.

AU - Grant, M. B.

PY - 2006/5

Y1 - 2006/5

N2 - Insulin-like growth factor-I (IGF-I) and its receptor (IGF-IR) are essential for normal ocular development and are expressed in numerous ocular cell types including lens epithelial cells, retinal pigment epithelial cells, Müller cells and endothelial cells. Endothelial cell proliferation is a common feature of proliferative retinopathies and involves abnormal growth of blood vessels within and on the surface of the retina. In an effort to inhibit the formation of these aberrant blood vessels, we cloned an IGF-IR ribozyme into an expression vector that limits expression of the ribozyme to proliferating endothelial cells. An endothelin enhancer and Cdc6 promoter chimera drives expression of the IGF-IR ribozyme. This promoter limited retinal expression of the reporter gene to proliferating endothelial cells in two mouse models of proliferative retinopathy. In addition, expression of the IGF-IR ribozyme by this promoter inhibited aberrant retinal angiogenesis in both models while preserving normal vessels. These results demonstrate the feasibility of IGF-IR ribozyme expression in a selective manner for safer treatment of abnormal angiogenesis associated with retinopathy.

AB - Insulin-like growth factor-I (IGF-I) and its receptor (IGF-IR) are essential for normal ocular development and are expressed in numerous ocular cell types including lens epithelial cells, retinal pigment epithelial cells, Müller cells and endothelial cells. Endothelial cell proliferation is a common feature of proliferative retinopathies and involves abnormal growth of blood vessels within and on the surface of the retina. In an effort to inhibit the formation of these aberrant blood vessels, we cloned an IGF-IR ribozyme into an expression vector that limits expression of the ribozyme to proliferating endothelial cells. An endothelin enhancer and Cdc6 promoter chimera drives expression of the IGF-IR ribozyme. This promoter limited retinal expression of the reporter gene to proliferating endothelial cells in two mouse models of proliferative retinopathy. In addition, expression of the IGF-IR ribozyme by this promoter inhibited aberrant retinal angiogenesis in both models while preserving normal vessels. These results demonstrate the feasibility of IGF-IR ribozyme expression in a selective manner for safer treatment of abnormal angiogenesis associated with retinopathy.

KW - Endothelial

KW - IGF-I

KW - Proliferating

KW - Promoter

KW - Retinopathy

KW - Ribozyme

UR - http://www.scopus.com/inward/record.url?scp=33645999993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645999993&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3302718

DO - 10.1038/sj.gt.3302718

M3 - Article

C2 - 16437130

AN - SCOPUS:33645999993

VL - 13

SP - 752

EP - 760

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 9

ER -